The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubat, T., Yagita, H., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.765 · Cited by 1,589
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., & Lenardo, M. J. (2007) · Nature Immunology · doi:10.1038/ni1536 · Cited by 1,286
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,211
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., & Tsuchiya, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.839 · Cited by 872
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 848
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
Prokunina, L., Castillejo-López, C., Öberg, F., Gunnarsson, I., Berg, L., Magnusson, V., Brookes, A. J., Tentler, D., Kristjansdóttir, H., Gröndal, G., et al. (2002) · Nature Genetics · doi:10.1038/ng1020 · Cited by 769
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Myasthenia gravis: past, present, and future
Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29894 · Cited by 691
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J., & Sharpe, A. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324228 · Cited by 639
Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 636
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
Probst, H. C., McCoy, K., Okazaki, T., Honjo, T., & van den Broek, M. (2005) · Nature Immunology · doi:10.1038/ni1165 · Cited by 554
Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells
Davidson, T. S., DiPaolo, R. J., Andersson, J., & Shevach, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4022 · Cited by 519
Kinter, A. L., Godbout, E. J., McNally, J. P., Sereti, I., Roby, G. A., O’Shea, M. A., & Fauci, A. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6738 · Cited by 513
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J. I., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
Nishimura, H. (1998) · International Immunology · doi:10.1093/intimm/10.10.1563 · Cited by 500
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis
Rodig, N., Ryan, T., Allen, J. A., Pang, H., Grabie, N., Chernova, T., Greenfield, E. A., Liang, S. C., Sharpe, A. H., Lichtman, A. H., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324270 · Cited by 492
The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells
Amarnath, S., Mangus, C. W., Wang, J. C. M., Wei, F., He, A., Kapoor, V., Foley, J. E., Massey, P. R., Felizardo, T. C., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003130 · Cited by 446
A critical role for the programmed death ligand 1 in fetomaternal tolerance
Guleria, I., Khosroshahi, A., Ansari, M. J., Habicht, A., Azuma, M., Yagita, H., Noelle, R. J., Coyle, A., Mellor, A. L., Khoury, S. J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050019 · Cited by 439
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., & Honjo, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505497102 · Cited by 437
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1
Zhang, X., Schwartz, J.-C. D., Guo, X., Bhatia, S., Cao, E., Chen, L., Zhang, Z.-Y., Edidin, M. A., Nathenson, S. G., & Almo, S. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00051-2 · Cited by 410
de Kleer, I. M., Wedderburn, L. R., Taams, L. S., Patel, A., Varsani, H., Klein, M., de Jager, W., Pugayung, G., Giannoni, F., Rijkers, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6435 · Cited by 400
Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis
Müller-Ladner, U., Pap, T., Gay, R. E., Neidhart, M., & Gay, S. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0047 · Cited by 334
Regulation of GLUT1 Gene Transcription by the Serine/Threonine Kinase Akt1
Barthel, A., Okino, S. T., Liao, J., Nakatani, K., Li, J., Whitlock, J. P., & Roth, R. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20281 · Cited by 330
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Gubbels Bupp, M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 325
Collagen-induced arthritis, an animal model of autoimmunity
Myers, L. K., Rosloniec, E. F., Cremer, M. A., & Kang, A. H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00480-3 · Cited by 316
TGFβ signalling in control of T-cell-mediated self-reactivity
Rubtsov, Y. P., & Rudensky, A. Y. (2007) · Nature Reviews Immunology · doi:10.1038/nri2095 · Cited by 311
Clinical Characteristics of Vogt–Koyanagi–Harada Syndrome in Chinese Patients
Yang, P., Ren, Y., Li, B., Fang, W., Meng, Q., & Kijlstra, A. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.040 · Cited by 306
State-of-the-art: rheumatoid arthritis
McInnes, I. B., & O'Dell, J. R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134684 · Cited by 303
β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis
Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Holländer, G. A., & Piali, L. (2002) · Nature Medicine · doi:10.1038/nm1202-792 · Cited by 301
PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
Tarrio, M. L., Grabie, N., Bu, D.-X., Sharpe, A. H., & Lichtman, A. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200389 · Cited by 288
Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8 + T-Cell–Mediated Injury in the Heart
Grabie, N., Gotsman, I., DaCosta, R., Pang, H., Stavrakis, G., Butte, M. J., Keir, M. E., Freeman, G. J., Sharpe, A. H., & Lichtman, A. H. (2007) · Circulation · doi:10.1161/circulationaha.107.709360 · Cited by 288
Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor
Chen, L., Sung, S.-S., Yip, M. L. R., Lawrence, H. R., Ren, Y., Guida, W. C., Sebti, S. M., Lawrence, N. J., & Wu, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025536 · Cited by 279
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
Wang, J., Okazaki, I.-M., Yoshida, T., Chikuma, S., Kato, Y., Nakaki, F., Hiai, H., Honjo, T., & Okazaki, T. (2010) · International Immunology · doi:10.1093/intimm/dxq026 · Cited by 270
Nishimura, H., Agata, Y., Kawasaki, A., Sato, M., Imamura, S., Minato, N., Yagita, H., Nakano, T., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.773 · Cited by 261
Defining and analyzing geoepidemiology and human autoimmunity
Shapira, Y., Agmon-Levin, N., & Shoenfeld, Y. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.018 · Cited by 260
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H. (2005) · Annals of Neurology · doi:10.1002/ana.20514 · Cited by 249
PD-1 Regulates Self-Reactive CD8+ T Cell Responses to Antigen in Lymph Nodes and Tissues
Keir, M. E., Freeman, G. J., & Sharpe, A. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5064 · Cited by 245
Polanczyk, M. J., Hopke, C., Vandenbark, A. A., & Offner, H. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20881 · Cited by 244
Nielsen, C., Hansen, D., Husby, S., Jacobsen, B. B., & Lillevang, S. T. (2003) · Tissue Antigens · doi:10.1046/j.1399-0039.2003.00136.x · Cited by 232
Tyrosinase Family Proteins Are Antigens Specific to Vogt-Koyanagi-Harada Disease
Yamaki, K., Gocho, K., Hayakawa, K., Kondo, I., & Sakuragi, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7323 · Cited by 230
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208
Appleman, L. J., van Puijenbroek, A. A. F. L., Shu, K. M., Nadler, L. M., & Boussiotis, V. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2729 · Cited by 201
Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., von Stebut, E., Probst, H.-C., van den Broek, M., Riethmacher, D., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.025 · Cited by 197
Nishimura, H., Honjo, T., & Minato, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.891 · Cited by 192
Raptopoulou, A. P., Bertsias, G., Makrygiannakis, D., Verginis, P., Kritikos, I., Tzardi, M., Klareskog, L., Catrina, A. I., Sidiropoulos, P., & Boumpas, D. T. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27500 · Cited by 191
Lucas, J. A., Menke, J., Rabacal, W. A., Schoen, F. J., Sharpe, A. H., & Kelley, V. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2513 · Cited by 189
Updating on the pathogenesis of systemic lupus erythematosus
Gualtierotti, R., Biggioggero, M., Penatti, A. E., & Meroni, P. L. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.007 · Cited by 184
Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S., Ireland, G., Luxenberg, D., Askew, G. R., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.006 · Cited by 183
Lin, S., Yen, J., Tsai, J., Tsai, W., Ou, T., Liu, H., & Chen, C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20040 · Cited by 175
Prokunina, L., Padyukov, L., Bennet, A., de Faire, U., Wiman, B., Prince, J., Alfredsson, L., Klareskog, L., & Alarcón‐Riquelme, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20280 · Cited by 173
The Link between the PDL1 Costimulatory Pathway and Th17 in Fetomaternal Tolerance
D’Addio, F., Riella, L. V., Mfarrej, B. G., Chabtini, L., Adams, L. T., Yeung, M., Yagita, H., Azuma, M., Sayegh, M. H., & Guleria, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002031 · Cited by 171
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M.-L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Martín‐Orozco, N., Wang, Y.-H., Yagita∥, H., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8291 · Cited by 156
A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese
Kong, E. K., Prokunina‐Olsson, L., Wong, W. H. S., Lau, C., Chan, T. M., Alarcón-Riquelme, M. E., & Lau, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20966 · Cited by 155
Activation-Induced Expression of Human Programmed Death-1 Gene in T-Lymphocytes
Vibhakar, R., Juan, G., Traganos, F., Darżynkiewicz, Z., & Finger, L. R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3493 · Cited by 149
Blair, P. J., Riley, J. L., Levine, B. L., Lee, K. P., Craighead, N., Francomano, T., Perfetto, S. J., Gray, G. S., Carreno, B. M., & June, C. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.12 · Cited by 143
Pathogenesis of multiple sclerosis: an update on immunology
Hemmer, B., Cepok, S., Nessler, S., & Sommer, N. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00001 · Cited by 139
Parry, R. V., Reif, K., Smith, G., Sansom, D. M., Hemmings, B. A., & Ward, S. G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271006 · Cited by 139
CD4 + CD25 + Regulatory Cells from Human Peripheral Blood Express Very High Levels of CD25 Ex Vivo
Baecher‐Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2003) · Novartis Foundation symposium · doi:10.1002/0470871628.ch6 · Cited by 136
Blair, P. J., Riley, J. L., Levine, B. L., Lee, K. P., Craighead, N., Francomano, T., Perfetto, S. J., Gray, G. S., Carreno, B. M., & June, C. H. (1998) · PubMed · Cited by 135
Intestinal Tolerance Is Converted to Autoimmune Enteritis upon PD-1 Ligand Blockade
Reynoso, E. D., Elpek, K. G., Francisco, L. M., Bronson, R. T., Bellemare‐Pelletier, A., Sharpe, A. H., Freeman, G. J., & Turley, S. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802769 · Cited by 135
Mechanisms of PDL1-mediated regulation of autoimmune diabetes
Guleria, I., Bupp, M. G., Dada, S., Fife, B. T., Tang, Q., Ansari, M. J., Trikudanathan, S., Vadivel, N., Fiorina, P., Yagita∥, H., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.013 · Cited by 134
Blank, C. U., Brown, I., Marks, R., Nishimura, H., Honjo, T., & Gajewski, T. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4574 · Cited by 131
Bertsias, G. K., Nakou, M., Choulaki, C., Raptopoulou, A., Papadimitraki, E. D., Goulielmos, G. N., Kritikos, H. D., Sidiropoulos, P. I., Tzardi, M. N., Kardassis, D., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24227 · Cited by 122
Ferreirós-Vidal, I., Gómez-Reino, J. J., Barros, F., Carracedo, Á., Carreira, P. E., Gonzáléz‐Escribano, F., Liz, M., Martin, J. J., Ordi‐Ros, J., Vicario, J. L., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20436 · Cited by 120
Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice
Wang, C.-J., Chou, F., Chu, C.-H., Wu, J., Lin, S., Chang, D., & Sytwu, H. (2008) · Diabetes · doi:10.2337/db07-1260 · Cited by 106
Pedersen, O. B., Svendsen, A. J., Ejstrup, L., Skytthe, A., Harris, J. R., & Junker, P. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740701824613 · Cited by 105
Lee, S., Lee, Y.-A., Woo, D. H., Song, R., Park, E., Ryu, M.-H., Kim, Y.-H., Kim, K. S., Hong, S.-J., Yoo, M. C., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2071 · Cited by 99
Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1
Amarnath, S., Costanzo, C., Mariotti, J., Ullman, J. L., Telford, W., Kapoor, V., Riley, J., Levine, B., June, C., Fong, T., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000302 · Cited by 97
van Noort, J. M., Bajramovic, J. J., Plomp, A. C., & van Stipdonk, M. J. B. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00181-8 · Cited by 97
Pauken, K. E., Jenkins, M. K., Azuma, M., & Fife, B. T. (2013) · Diabetes · doi:10.2337/db12-1475 · Cited by 95
Fierabracci, A., Milillo, A., Locatelli, F., & Fruci, D. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.04.007 · Cited by 87
Self-citationThorburn, C. M., Prokunina‐Olsson, L., Sterba, K., Lum, R. F., Seldin, M. F., Alarcón-Riquelme, M. E., & Criswell, L. A. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364383 · Cited by 86
Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Alarcón-Riquelme, M. E. (2004) · Arthritis Research · doi:10.1186/ar1203 · Cited by 74
Ni, R., Ihara, K., Miyako, K., Kuromaru, R., Inuo, M., Kohno, H., & Hara, T. (2007) · Human Genetics · doi:10.1007/s00439-006-0309-8 · Cited by 73
Genetic background of multiple sclerosis
Sadovnick, A. D. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.007 · Cited by 69
NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26)
Song, M.-N., Park, J. E., Park, S. G., Lee, D. H., Choi, H., Park, B. C., Ryu, S. E., Kim, J. H., & Cho, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.069 · Cited by 68
The effects of PDL-Ig on collagen-induced arthritis
Wang, G., Hu, P., Yang, J. L., Shen, G., & Wu, X. (2009) · Rheumatology International · doi:10.1007/s00296-009-1249-0 · Cited by 68
Are autoimmune diseases predictable?
Tobón, G. J., Pers, J., Cañas, C. A., Rojas‐Villarraga, A., Youinou, P., & Anaya, J. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.004 · Cited by 68
The genomics of autoimmune disease in the era of genome-wide association studies and beyond
Lessard, C. J., Ice, J. A., Adrianto, I., Wiley, G. B., Kelly, J. A., Gaffney, P. M., Montgomery, C. G., & Moser, K. L. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.003 · Cited by 67
Gianchecchi, E., Palombi, M., & Fierabracci, A. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.003 · Cited by 63
Self-citationAssociation of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus
Velázquez-Cruz, R., Orozco, L., Espinosa-Rosales, F., Carreño-Manjarrez, R., Solís-Vallejo, E., López-Lara, N. D., Ruiz-López, I. K., Rodríguez-Lozano, A. L., Estrada-Gil, J. K., Jiménez-Sánchez, G., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201767 · Cited by 62
IgM predominance in autoimmune disease: Genetics and gender
Duarte-Rey, C., Bogdanos, D. P., Leung, P. S. C., Anaya, J., & Gershwin, M. E. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.12.001 · Cited by 61
Differential Effects of Costimulatory Pathway Modulation on Corneal Allograft Survival
Watson, M. P., George, A. J. T., & Larkin, F. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1597 · Cited by 57
Hayashi, M., Kouki, T., Takasu, N., Sunagawa, S., & Komiya, I. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0649 · Cited by 57
Recent findings on genes associated with inflammatory disease
Yamada, R., & Ymamoto, K. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.061 · Cited by 56
Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells
Totsuka, T., Kanai∥, T., Makita, S., Fujii, R., Nemoto, Y., Oshima, S., Okamoto, R., Koyanagi, A., Akiba, H., Okumura, K., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425109 · Cited by 51
Sanghera, D. K., Manzi, S., Bontempo, F. A., Nestlerode, C. S., & Kamboh, M. I. (2004) · Human Genetics · doi:10.1007/s00439-004-1172-0 · Cited by 50
PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders
James, E. S., Harney, S. M. J., Wordsworth, B. P., Cookson, W., Davis, S. J., & Moffatt, M. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364223 · Cited by 48
Meng, Q., Yang, P., Li, B., Zhou, H., Huang, X., Zhu, L., Ren, Y., & Kijlstra, A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0201 · Cited by 46
Tag SNP screening of the PDCD1 gene for association with Graves’ disease
Newby, P., Roberts‐Davies, E. L., Brand, O. J., Heward, J. M., Franklyn, J. A., Gough, S. C. L., & Simmonds, M. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02848.x · Cited by 44
Ferreirós-Vidal, I., D’Alfonso, S., Papasteriades, C. A., Skopouli, F. N., Marchini, M., Scorza, R., Migliaresi, S., Sebastiani, G. D., Endreffy, E., Mavromati, M., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364370 · Cited by 40
Wang, C.-H., Li, Y.-X., Proctor, T., Vandenbark, A., & Offner, H. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22181 · Cited by 39
Meng, Q., Liu, X., Yang, P., Hou, S., Du, L., Zhou, H., & Kijlstra, A. (2009) · PubMed · Cited by 37
Liu, J., Zhang, F., Liang, Y., Xiao, F., Zhang, S. ‐., Cheng, Y., Yuan, C., Chen, Q., Yang, S., & Zhang, X. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03087.x · Cited by 35
Management of inflammatory bowel disease in adults
Katz, J. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00287.x · Cited by 34
Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis
Sakthivel, P., Ramanujam, R., Wang, X. B., Pirskanen, R., & Lefvert, A. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.019 · Cited by 27
Soleimanifar, N., Amirzargar, A. A., Mahmoudi, M., Pourfathollah, A. A., Azizi, E., Jamshidi, A., Rezaei, N., Tahoori, M. T., Bidad, K., Nikbin, B., et al. (2010) · Inflammation · doi:10.1007/s10753-010-9282-4 · Cited by 26
Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I Diabetes
Kornete, M., & Piccirillo, C. A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.007 · Cited by 25
No evidence of association of the PDCD1 gene with Type 1 diabetes
Fawwaz, S., Nikamo, P., Törn, C., Landin‐Olsson, M., Lernmark, Å., Alarcón-Riquelme, M. E., Kockum, I. S., & the Diabetes Incidence in Sweden Study Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02297.x · Cited by 24
Targeting pathogenic T helper cell memory
Chang, H., & Radbruch, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140954 · Cited by 16
No evidence of association between genetic variants of the PDCD1 ligands and SLE
Abelson, A.-K., Johansson, C., Kozyrev, S. V., Kristjansdottir, H., Gunnarsson, I., Svenungsson, E., Jönsen, A., Lima, G., Scherbarth, H. R., Gamron, S., et al. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364360 · Cited by 15
The role of B cells in regulating the magnitude of immune response
Nagafuchi, S. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00235.x · Cited by 12
Polymorphisms in PDCD1 gene are not associated with Wegener’s granulomatosis
Sakthivel, P., Giscombe, R., Ramanujam, R., & Lefvert, A. K. (2009) · Rheumatology International · doi:10.1007/s00296-009-0952-1 · Cited by 10
Fierabracci, A., & Ayroldi, E. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798157586 · Cited by 8
Self-citation
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
The Pathogenesis of Sepsis and Potential Therapeutic Targets
Huang, M., Cai, S., & Su, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215376 · Cited by 776
Application of PD-1 Blockade in Cancer Immunotherapy
Wu, X., Gu, Z., Chen, Y., Chen, B., Chen, W., Weng, L., & Liu, X. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.03.006 · Cited by 531
Beatson, R., Tajadura-Ortega, V., Achkova, D., Picco, G., Tsourouktsoglou, T.-D., Klausing, S., Hillier, M., Maher, J., Noll, T., Crocker, P. R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3552 · Cited by 378
Metadata
- Authors
- Gianchecchi, E., Delfino, D. V., & Fierabracci, A.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 12
- Issue
- 11
- Pages
- 1091-1100
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2047359339
- Cited by
- 270
- References
- 143
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.